The objectives of this thesis, aimed to reduce overtreatment of ductal carcinoma in situ (DCIS) of the breast, were : 1) to evaluate the risk of underestimation after a diagnosis of DCIS and the interrater reliability in the histopathological classification of DCIS, important conditions in order to safely adopt an active surveillance strategy for low-risk DCIS, 2) to investigate associations of clinicopathological factors with the risk of developing ipsilateral invasive breast cancer after treatment of DCIS and 3) to analyze the extent of response of DCIS, adjacent to HER2-positive breast cancer, to neoadjuvant systemic therapy and to investigate associations of clinicopathological factors with DCIS response.We have taken significant steps ...
The incidence of ductal carcinoma in situ (DCIS), a nonin-vasive form of breast cancer, has increase...
The high proportion of ductal carcinoma in situ (DCIS) presented in mammographic screening and the r...
Ductal carcinoma in situ (DCIS) is a precursor of invasive breast carcinoma (IBC). The DCIS componen...
Breast cancer is the most common cancer form and a leading cause of death in women worldwide. Ductal...
Ductal carcinoma in situ (DCIS) now represents 20–25% of all ‘breast cancers’ consequent upon detect...
AbstractWith the widespread adoption of population-based breast cancer screening, ductal carcinoma i...
Ductal carcinoma in situ (DCIS) is a proliferation of presumably malignant epithelial cells within t...
As a result of mammographic detection, ductal carcinoma in situ (DCIS) is an increasing problem in b...
Aim: The ductal carcinoma in situ is a malignant proliferation of mammary ductal epithelial cells wi...
Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer. It accounts f...
Since population-based breast cancer screening was implemented in the Netherlands, the incidence of ...
Ductal carcinoma in situ (DCIS) of the breast is a nonobligate precursor of invasive breast cancer, ...
INTRODUCTION: The role of ductal carcinoma in situ (DCIS) component on the outcome of invasive breas...
Ductal carcinoma in situ (DCIS) is noninvasive breast cancer that encompasses a wide spectrum of dis...
Purpose: Ductal carcinoma in situ (DCIS) is present in more than half of HER2-positive invasive brea...
The incidence of ductal carcinoma in situ (DCIS), a nonin-vasive form of breast cancer, has increase...
The high proportion of ductal carcinoma in situ (DCIS) presented in mammographic screening and the r...
Ductal carcinoma in situ (DCIS) is a precursor of invasive breast carcinoma (IBC). The DCIS componen...
Breast cancer is the most common cancer form and a leading cause of death in women worldwide. Ductal...
Ductal carcinoma in situ (DCIS) now represents 20–25% of all ‘breast cancers’ consequent upon detect...
AbstractWith the widespread adoption of population-based breast cancer screening, ductal carcinoma i...
Ductal carcinoma in situ (DCIS) is a proliferation of presumably malignant epithelial cells within t...
As a result of mammographic detection, ductal carcinoma in situ (DCIS) is an increasing problem in b...
Aim: The ductal carcinoma in situ is a malignant proliferation of mammary ductal epithelial cells wi...
Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer. It accounts f...
Since population-based breast cancer screening was implemented in the Netherlands, the incidence of ...
Ductal carcinoma in situ (DCIS) of the breast is a nonobligate precursor of invasive breast cancer, ...
INTRODUCTION: The role of ductal carcinoma in situ (DCIS) component on the outcome of invasive breas...
Ductal carcinoma in situ (DCIS) is noninvasive breast cancer that encompasses a wide spectrum of dis...
Purpose: Ductal carcinoma in situ (DCIS) is present in more than half of HER2-positive invasive brea...
The incidence of ductal carcinoma in situ (DCIS), a nonin-vasive form of breast cancer, has increase...
The high proportion of ductal carcinoma in situ (DCIS) presented in mammographic screening and the r...
Ductal carcinoma in situ (DCIS) is a precursor of invasive breast carcinoma (IBC). The DCIS componen...